New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 19, 2018 - The FDA announced the discontinuation of Vernalis Therapeutics’ Moxatag (amoxicillin) extended-release tablets.
Download PDF
Return to publications
